AIGNOSTICS

Introducing HETA Clinical: a new family of pan-cancer AI products that speed up pathology workflows and reduce failed molecular tests, starting with four that measure slide quality, tumor presence, mitoses and tumor cellularity. For research use only. aignostics.com/clinical/heta-…

Introducing PathoSearch: a visual search engine for #pathology cases. From a single screenshot of a region of interest on an H&E slide, it retrieves morphologically similar, diagnosed reference cases in seconds. Now in early access: aignostics.com/products/patho…

#PathTwitter #PathX

First time at #ESPCongress — and we're bringing our first clinical application! 🎉

Booth #548: live demo of our clinical reference lookup for tough #pathology cases, plus latest on our H&E tissue profiling app.

Book a meeting: aignostics.com/contact?utm_so…

The #aignostics team is heading to #ASCO2024!

Interested in hearing about how we’re transforming precision medicine with our industry-leading foundation model and advanced machine learning algorithms? Let’s connect on June 2-3: lnkd.in/e7eTNxEw

#ASCO24 #PrecisionMedicine

We are delighted to announce that Aignostics has been awarded a 3 year grant under the “ProFIT” initiative. It was approved by the Investitionsbank Berlin (IBB) and is co-financed by the European Union under the EU Regional Development Fund (ERDF).

aignostics.com/news/aignostic…